Level Biotechnology Inc
TPEX:3118
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Level Biotechnology Inc
TPEX:3118
|
TW |
|
E
|
Energy Resources Of Australia Ltd
F:EJ7
|
AU |
|
A
|
Acset Indonusa Tbk PT
IDX:ACST
|
ID |
|
W
|
Warner Bros Discovery Inc
DUS:J5A
|
US |
|
C
|
Carnival Corp
LSE:0EV1
|
US |
|
G
|
Grand House Mulia Tbk PT
IDX:HOMI
|
ID |
|
H
|
Hercules PLC
LSE:HERC
|
UK |
|
G
|
General Mills Inc
XETRA:GRM
|
US |
|
Embotelladora Andina SA
F:AKOA
|
CL |
|
P
|
Prima Multi Usaha Indonesia Tbk PT
IDX:PMUI
|
ID |
|
K
|
KMW Co Ltd
KOSDAQ:032500
|
KR |
|
C
|
Calgro M3 Holdings Ltd
JSE:CGR
|
ZA |
|
StoneBridge Acquisition II Corp
NASDAQ:APAC
|
US |
|
A
|
Asia Commercial Joint Stock Bank
VN:ACB
|
VN |
|
Marui Group Co Ltd
OTC:MAURF
|
JP |
|
Tesla Inc
NASDAQ:TSLA
|
US |
Bankruptcy Probability
Level Biotechnology Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Level Biotechnology Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
L
|
Level Biotechnology Inc
TPEX:3118
|
1B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
McKesson Corp
NYSE:MCK
|
107.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
61.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
55.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
61.1B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
47.3B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
45.9B HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Galenica AG
SIX:GALE
|
4.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
|
32B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Level Biotechnology Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Level Biotechnology Inc has total debt of 2.7m TWD. This includes both short-term (0 TWD) and long-term (2.7m TWD) debt.
You can find a full breakdown on its Balance Sheet.